Instituto do Cancer Brasil - Unidade Taubate

Taubaté 12030-200

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Non Small Cell Lung Cancer

Studies at this site

• Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) — Running, not enrolling
• Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations — Running, not enrolling